Hypertension and increased risk for AD?
Major journal reports study findings. A study in the JAMA Neurology suggests that controlling or preventing risk factors such as hypertension earlier in life may limit or delay the brain… read more.
Major journal reports study findings. A study in the JAMA Neurology suggests that controlling or preventing risk factors such as hypertension earlier in life may limit or delay the brain… read more.
Research illuminates a molecular mechanism for why a stimulating environment may protect against Alzheimer’s Disease.
The first large, population-based study to follow children with attention-deficit hyperactivity disorder (ADHD) into adulthood shows that ADHD often doesn’t “go away,” and that children with ADHD are… read more.
World Health Matters – France – by Gary Finnegan – The detrimental effects of obesity are well-documented with public health specialists warning of a tidal wave of diabetes… read more.
World Health Matters – China – by Gary Finnegan – A study of nearly 6,000 people in five provinces in China has shown that people exposed to passive… read more.
FDA Highlights by Bruce Sylvester – According to a study published online on Nov. 20, 2012 in Arthritis and Rheumatism, rituximab appears to benefit patients with antiphospholipid antibodies… read more.
FDA Highlights by Bruce Sylvester – Women who start hormone therapy within 5 years of menopause onset could reduce their risk of developing Alzheimer’s disease,
FDA Highlights by Bruce Sylvester – Women who start hormone therapy within 5 years of menopause onset could reduce their risk of developing Alzheimer’s disease,
http://www.eurekalert.org/multimedia/pub/51742.php?from=230078 Researchers have shown that transplanting stem cells derived from normal mouse blood vessels into the hearts of mice that model the pathology associated with Duchenne muscular dystrophy… read more.
by Gary Finnegan – EMA Highlights – The first radiopharmaceutical for positron emission tomography (PET) imaging of β-amyloid neuritic plaque density has been approved by the EMA’s Committee… read more.
by Gary Finnegan – EMA Highlights – The EMA has given the green light to a new vaccine for bacterial meningitis. Bexsero, by Novartis, provides broad coverage against… read more.
by Gary Finnegan – World Health Matters (France) – A new study has suggested that low levels of insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3… read more.